The Molecular Biology of Myeloma

David S. Siegel, MD, PhD
Video Categories: Targeted Therapies

Dr. David S. Siegel discusses the importance of understanding the molecular biology of myeloma. Physicians can now look at and offer alternative treatments to patients that they identify will most likely do poorly with traditional treatment. He believes this area will develop quickly over the next 2 to 5 years.

September 20, 2013

Value Proposition of Personalized Medicine

John Hennessy discusses the benefits of the “personalized medicine toolkit” to help make better decisions

September 20, 2013

The Greatest Value of Personalized Medicine

Grant Lawless discusses the definition of value in personalized medicine from different perspectives